Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Giral

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
British Journal of Pharmacology|July 1, 1996
Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shockM Giral, D Balsa, R Ferrando, et al.
Journal of Medicinal Chemistry|January 19, 1996
Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonistsE Carceller, M Merlos, M Giral, et al.
Journal of Pharmacological and Toxicological Methods|September 1, 1996
Characterization of [3H]apafant binding to PAF receptor on rabbit platelet membranes: a comparison of a microplate filtration system and a standard methodD Balsa, M Merlos, M Giral, et al.
Human Immunology|October 3, 1998
Impact of the MHC-encoded HLA-DMA, DMB, and LMP2 gene polymorphisms on kidney graft outcomeD Chevrier, M Giral, J Y Muller, et al.
Laboratory Animals|June 19, 2014
Anaesthetic effects in the ferret of alfaxalone alone and in combination with medetomidine or tramadol: a pilot studyM Giral, D C García-Olmo, M Gómez-Juárez, et al.
Transplantation Proceedings|June 4, 2013
Early steroid withdrawal compared with steroid avoidance correlates with graft failure among kidney transplant recipients with an history of diabetesD Cantarovich, B Hodemon-Corne, K Trébern-Launay, et al.
Lancet (London, England)|March 21, 1998
Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimensJ Dantal, M Hourmant, D Cantarovich, et al.
Journal of Medicinal Chemistry|October 30, 1992
(Pyridylcyanomethyl)piperazines as orally active PAF antagonistsE Carceller, C Almansa, M Merlos, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 11, 2012
A need for biomarkers of operational tolerance in liver and kidney transplantationM-C Londoño, R Danger, M Giral, et al.
British Journal of Pharmacology|December 1, 1991
Effects of PAF-antagonists in mouse ear oedema induced by several inflammatory agentsM Merlos, L A Gómez, M Giral, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
British Journal of Pharmacology|July 1, 1996
Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shockM Giral, D Balsa, R Ferrando, et al.
Journal of Medicinal Chemistry|January 19, 1996
Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonistsE Carceller, M Merlos, M Giral, et al.
Journal of Pharmacological and Toxicological Methods|September 1, 1996
Characterization of [3H]apafant binding to PAF receptor on rabbit platelet membranes: a comparison of a microplate filtration system and a standard methodD Balsa, M Merlos, M Giral, et al.
Human Immunology|October 3, 1998
Impact of the MHC-encoded HLA-DMA, DMB, and LMP2 gene polymorphisms on kidney graft outcomeD Chevrier, M Giral, J Y Muller, et al.
Laboratory Animals|June 19, 2014
Anaesthetic effects in the ferret of alfaxalone alone and in combination with medetomidine or tramadol: a pilot studyM Giral, D C García-Olmo, M Gómez-Juárez, et al.
Transplantation Proceedings|June 4, 2013
Early steroid withdrawal compared with steroid avoidance correlates with graft failure among kidney transplant recipients with an history of diabetesD Cantarovich, B Hodemon-Corne, K Trébern-Launay, et al.
Lancet (London, England)|March 21, 1998
Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimensJ Dantal, M Hourmant, D Cantarovich, et al.
Journal of Medicinal Chemistry|October 30, 1992
(Pyridylcyanomethyl)piperazines as orally active PAF antagonistsE Carceller, C Almansa, M Merlos, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 11, 2012
A need for biomarkers of operational tolerance in liver and kidney transplantationM-C Londoño, R Danger, M Giral, et al.
British Journal of Pharmacology|December 1, 1991
Effects of PAF-antagonists in mouse ear oedema induced by several inflammatory agentsM Merlos, L A Gómez, M Giral, et al.
Pageof 8